Arcotech Ltd has announced a major restructuring of its capital base, raising its authorized equity share capital to Rs 136 crore to facilitate future funding. The company also approved the private placement of non-convertible debentures (NCDs) worth Rs 115 crore with a four-year tenure. Additionally, the firm recommended the appointment of M/s. Agarwal U R S & CO. as its new statutory auditor for a five-year term, subject to shareholder approval at the upcoming Annual General Meeting.
Arcotech Ltd Announces Capital Expansion and Rs 115 Crore Debt Raise
Fundraising: Up to Rs 115 crore via NCDs.
Authorized Equity: Increased from Rs 21 crore to Rs 136 crore.
Reader Takeaway: The company is aggressively restructuring its capital base to support future operations and debt-led financing needs.
What just happened
Arcotech Ltd’s Board has approved a significant plan to bolster its financial structure. This includes a private placement of 1,150 unlisted, senior, secured, redeemable NCDs, each with a face value of Rs 10 lakh, totaling Rs 115 crore. The debt instrument carries a tenure of four years. Simultaneously, the company is seeking to increase its authorized equity share capital to Rs 136 crore—a massive jump from its current Rs 21 crore capacity.
Why this matters
The expansion of authorized share capital suggests that the management is preparing for future equity-linked fundraising or corporate actions. By reclassifying existing preference shares, the company aims to gain greater flexibility in its capital structure. The NCD issuance, while unlisted, provides immediate liquidity, although the specific cost of debt (interest rates) and collateral details remain to be finalized by the Board.
Governance and Auditor Update
Beyond the capital restructuring, Arcotech is transitioning its audit oversight. The company has recommended M/s. Agarwal U R S & CO. to serve as the new statutory auditor for a five-year term. This transition is slated to be finalized during the 45th Annual General Meeting (AGM) currently scheduled for September 29, 2026.
Risks to watch
Investors should closely track the eventual terms of the NCD issuance, particularly interest rates, as they will directly impact the company's debt-servicing capability. Furthermore, the expansion of authorized capital, while facilitating growth, often precedes potential dilution for existing shareholders if new equity is issued in the future. Finally, the proposed changes are subject to final approval by shareholders, making the upcoming AGM a key event for institutional and retail investors alike.